Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
08:54

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

2.3K

Oral 8-aminoguanine against age-related retinal degeneration

Abhishek Vats1, Yibo Xi1, Amanda S Wolf-Johnston2

  • 1Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Communications Biology
|May 26, 2025
PubMed

Insights

An oral agent, 8-aminoguanine (8-AG), effectively preserves vision in aging rats by reducing retinal degeneration and inflammation. This promising compound offers potential for treating age-related vision decline.

Area of Science:

  • Ophthalmology
  • Gerontology
  • Pharmacology

Background:

  • Age-related vision decline, often linked to retinal aging, increases susceptibility to conditions like age-related macular degeneration.
  • Current oral treatment options for age-related retinal degeneration are limited.

Purpose of the Study:

  • To investigate the efficacy of 8-aminoguanine (8-AG) as an oral therapeutic agent for age-related retinal degeneration.
  • To evaluate the protective effects of 8-AG on retinal structure and function in an aged rat model.

Main Methods:

  • Administration of 8-AG in drinking water to aged Fischer 344 rats for 8 or 17 weeks.
  • Assessment of retinal structure (thickness, photoreceptor integrity) and function (electroretinogram responses).
  • Analysis of molecular markers including apoptosis, oxidative damage, microglial/macrophage activation, and inflammatory markers.

Main Results:

  • 8-AG treatment significantly preserved retinal thickness and photoreceptor integrity.
  • Improved electroretinogram responses indicated preserved retinal function in 8-AG treated rats.
  • 8-AG reduced retinal apoptosis, oxidative stress, inflammation, and microglial/macrophage activation.

Conclusions:

  • 8-aminoguanine demonstrates significant protective effects against age-related retinal degeneration in a rat model.
  • 8-AG mitigates key pathological hallmarks of retinal aging, including inflammation and oxidative damage.
  • 8-AG shows potential as a therapeutic anti-aging compound for age-related vision impairment.

More Related Videos

Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases07:22

Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases

Published on: March 11, 2016

12.0K
Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography10:24

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography

Published on: February 19, 2014

14.2K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
8